共 50 条
- [21] NON-MUSCLE INVASIVE BLADDER CANCER SUBTYPES WITH DIFFERENTIAL RESPONSE TO INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT JOURNAL OF UROLOGY, 2022, 207 (05): : E77 - E77
- [25] RE-EVALUATION OF INTRAVESICAL GEMCITABINE IN BACILLUS CALMETTE-GUERIN UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER JOURNAL OF UROLOGY, 2021, 206 : E299 - E299
- [26] Intravesical Gemcitabine for High Risk, Nonmuscle Invasive Bladder Cancer after Bacillus Calmette-Guerin Treatment Failure JOURNAL OF UROLOGY, 2013, 190 (05): : 1686 - 1691
- [28] SEQUENTIAL INTRAVESICAL GEMCITABINE AND DOCETAXEL FOR THE SALVAGE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER JOURNAL OF UROLOGY, 2015, 193 (04): : E301 - E301
- [29] INTRAVESICAL GEMCITABINE FOR HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER AFTER BACILLUS CALMETTE-GURIN TREATMENT FAILURE JOURNAL OF UROLOGY, 2013, 189 (04): : E697 - E698